After chronic aripiprazole administration to the 5xFAD AD mouse model, aripiprazole effectively inhibited βA plaque deposition in the hippocampus and suppressed βA signaling cascades, as shown by CTFβ and βA and downregulation of the βA-cleaving enzyme, BACE1. This evidence concerns the gene BACE1 and Alzheimer disease.